{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:16:38Z","timestamp":1791461798619,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s11886-024-02029-2","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T13:02:20Z","timestamp":1708952540000},"page":"233-244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mechanical Circulatory Support for High-Risk Percutaneous Coronary Intervention"],"prefix":"10.1007","volume":"26","author":[{"given":"Silvia","family":"Moscardelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Masoomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Villablanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Jabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankitkumar K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Azzalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"2029_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.amjcard.2013.10.039","volume":"113","author":"AE Bortnick","year":"2014","unstructured":"Bortnick AE, Epps KC, Selzer F, Anwaruddin S, Marroquin OC, Srinivas V, et al. Five-year follow-up of patients treated for coronary artery disease in the face of an increasing burden of co-morbidity and disease complexity (from the NHLBI Dynamic Registry). Am J Cardiol. 2014;113:573\u20139.","journal-title":"Am J Cardiol"},{"key":"2029_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcin.2021.09.039","volume":"15","author":"M Protty","year":"2022","unstructured":"Protty M, Sharp ASP, Gallagher S, Farooq V, Spratt JC, Ludman P, et al. Defining percutaneous coronary intervention complexity and risk: an analysis of the United Kingdom BCIS database 2006\u20132016. JACC Cardiovasc Interv. 2022;15:39\u201349.","journal-title":"JACC Cardiovasc Interv"},{"key":"2029_CR3","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jcin.2023.02.005","volume":"16","author":"G Khandelwal","year":"2023","unstructured":"Khandelwal G, Spirito A, Tanner R, Koshy AN, Sartori S, Salehi N, et al. Validation of UK-BCIS CHIP score to predict 1-year outcomes in a contemporary united states population. JACC Cardiovasc Interv. 2023;16:1011\u201320.","journal-title":"JACC Cardiovasc Interv"},{"key":"2029_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.21037\/atm.2017.09.26","volume":"6","author":"M Nayyar","year":"2018","unstructured":"Nayyar M, Donovan KM, Khouzam RN. When more is not better\u2014appropriately excluding patients from mechanical circulatory support therapy. Ann Transl Med. 2018;6:9\u20139.","journal-title":"Ann Transl Med"},{"key":"2029_CR5","doi-asserted-by":"crossref","unstructured":"Kim SH, Baumann S, Behnes M, Borggrefe M, Akin I. Patient selection for protected percutaneous coronary intervention: Who benefits the most? Cardiol Clin. W.B. Saunders; 2020:507\u201316.","DOI":"10.1016\/j.ccl.2020.06.004"},{"key":"2029_CR6","first-page":"871","volume":"9","author":"TM Atkinson","year":"2016","unstructured":"Atkinson TM, Ohman EM, O\u2019neill WW, Rab T, Cigarroa JE. Statement from the interventional council of the ACC a practical approach to mechanical circulatory support in patients undergoing percutaneous coronary intervention an interventional perspective. JACC: Cardiovasc Interv. 2016;9:871\u201383.","journal-title":"JACC: Cardiovasc Interv"},{"key":"2029_CR7","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79:e21\u2013129.","journal-title":"J Am Coll Cardiol"},{"key":"2029_CR8","doi-asserted-by":"publisher","first-page":"E011534","DOI":"10.1161\/CIRCINTERVENTIONS.121.011534","volume":"15","author":"M Zeitouni","year":"2022","unstructured":"\u2022\u2022 Zeitouni M, Marquis-Gravel G, Smilowitz NR, Zakroysky P, Wojdyla DM, Amit AP, et al. Prophylactic mechanical circulatory support use in elective percutaneous coronary intervention for patients with stable coronary artery disease. Circ Cardiovasc Interv. 2022;15:E011534. Findings from this study suggest that the use of prophylactic MCS has increased over time for elective PCI in patients with stable coronary artery disease. Intra-aortic balloon pump was associated with higher major adverse cardiac events but lower risk of procedural complications compared with other MCS.","journal-title":"Circ Cardiovasc Interv"},{"key":"2029_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s12181-017-0208-3","volume":"11","author":"N Werner","year":"2017","unstructured":"Werner N, Akin I, Al-Rashid F, Bauer T, Ibrahim K, Karatolios K, et al. Expertenkonsensus zum praktischen Einsatz von Herzkreislaufunterst\u00fctzungssystemen bei Hochrisiko-Koronarinterventionen. Kardiologe. 2017;11:460\u201372.","journal-title":"Kardiologe"},{"key":"2029_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jcin.2016.02.046","volume":"9","author":"TM Atkinson","year":"2016","unstructured":"Atkinson TM, Ohman EM, O\u2019Neill WW, Rab T, Cigarroa JE. A practical approach to mechanical circulatory support in patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2016;9:871\u201383.","journal-title":"JACC Cardiovasc Interv"},{"key":"2029_CR11","first-page":"44","volume":"13","author":"KE Kearney","year":"2019","unstructured":"Kearney KE, Mccabe JM, Riley RF. Patient selection and procedural strategy are key in treating this evolving patient population. Hemodynamic Support for High-Risk PCI. Cardiac Interv Today. 2019;13:44\u20138.","journal-title":"Cardiac Interv Today"},{"key":"2029_CR12","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ejhf.268","volume":"17","author":"JL Grodin","year":"2015","unstructured":"Grodin JL, Mullens W, Dupont M, Wu Y, Taylor DO, Starling RC, et al. Prognostic role of cardiac power index in ambulatory patients with advanced heart failure. Eur J Heart Fail. 2015;17:689\u201396.","journal-title":"Eur J Heart Fail"},{"key":"2029_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.MAT.0000159381.97773.9B","volume":"51","author":"TG Papaioannou","year":"2005","unstructured":"Papaioannou TG, Stefanadis C. Basic principles of the intraaortic balloon pump and mechanisms affecting its performance. ASAIO J. 2005;51:296\u2013300.","journal-title":"ASAIO J"},{"key":"2029_CR14","doi-asserted-by":"crossref","unstructured":"Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention a randomized controlled trial. J Am Med Assoc. 2010;308:867\u201374. Available from: https:\/\/jamanetwork.com\/","DOI":"10.1001\/jama.2010.1190"},{"key":"2029_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCULATIONAHA.112.132209","volume":"127","author":"D Perera","year":"2013","unstructured":"Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, et al. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): A randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation. 2013;127:207\u201312.","journal-title":"Circulation"},{"key":"2029_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1055\/s-0038-1676369","volume":"28","author":"JJ Glazier","year":"2019","unstructured":"Glazier JJ, Kaki A. The impella device: Historical background, clinical applications and future directions. Int J Angiol. 2019;28:118\u201323.","journal-title":"Int J Angiol"},{"key":"2029_CR17","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.jacc.2015.03.036","volume":"65","author":"CS Rihal","year":"2015","unstructured":"Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. 2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care. J Am Coll Cardiol. 2015;65:e7\u201326.","journal-title":"J Am Coll Cardiol"},{"key":"2029_CR18","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.jcin.2023.05.043","volume":"16","author":"CJ Van Edom","year":"2023","unstructured":"Van Edom CJ, Gramegna M, Baldetti L, Beneduce A, Castelein T, Dauwe D, et al. Management of bleeding and hemolysis during percutaneous microaxial flow pump support: a practical approach. JACC Cardiovasc Interv. 2023;16:1707\u201320.","journal-title":"JACC Cardiovasc Interv"},{"key":"2029_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcin.2008.11.005","volume":"2","author":"SR Dixon","year":"2009","unstructured":"Dixon SR, Henriques JPS, Mauri L, Sjauw K, Civitello A, Kar B, et al. A prospective feasibility trial investigating the use of the impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial). JACC Cardiovasc Interv. 2009;2:91\u20136.","journal-title":"JACC Cardiovasc Interv."},{"key":"2029_CR20","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA","volume":"126","author":"O Ww","year":"2012","unstructured":"Ww O, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, et al. Interventional cardiology a prospective, randomized clinical trial of hemodynamic support with impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention The PROTECT II Study. Circulation. 2012;126:1717\u201327. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.","journal-title":"Circulation."},{"key":"2029_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.amjcard.2013.09.008","volume":"113","author":"GD Dangas","year":"2014","unstructured":"Dangas GD, Kini AS, Sharma SK, Henriques JPS, Claessen BE, Dixon SR, et al. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). Am J Cardiol. 2014;113:222\u20138.","journal-title":"Am J Cardiol."},{"key":"2029_CR22","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.jacc.2009.09.018","volume":"54","author":"KD Sjauw","year":"2009","unstructured":"Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, et al. Supported high-risk percutaneous coronary intervention with the impella 2.5 device. The Europella Registry. J Am Coll Cardiol. 2009;54:2430\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"2029_CR23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ccd.23403","volume":"80","author":"B Maini","year":"2012","unstructured":"Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T, Wohns D, et al. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The USpella Registry. Catheter Cardiovasc Interv. 2012;80:717\u201325.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2029_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ahj.2022.02.006","volume":"248","author":"WW O\u2019Neill","year":"2022","unstructured":"\u2022 O\u2019Neill WW, Anderson M, Burkhoff D, Grines CL, Kapur NK, Lansky AJ, et al. Improved outcomes in patients with severely depressed LVEF undergoing percutaneous coronary intervention with contemporary practices. Am Heart J. 2022;248:139\u201349. The PROTECT III study demonstrates improved completeness of revascularization, less bleeding, and improved 90-day clinical outcomes compared to matched patients from the PROTECT II trial (Impella-supported high-risk percutaneous coronary intervention among patients with severely depressed LVEF.","journal-title":"Am Heart J"},{"key":"2029_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ccd.29235","volume":"97","author":"M Afana","year":"2021","unstructured":"Afana M, Altawil M, Basir M, Alqarqaz M, Alaswad K, Eng M, et al. Transcaval access for the emergency delivery of 5.0 liters per minute mechanical circulatory support in cardiogenic shock. Catheter Cardiovasc Interv. 2021;97:555\u201364.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2029_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.009657","volume":"14","author":"JM McCabe","year":"2021","unstructured":"McCabe JM, Kaki AA, Pinto DS, Kirtane AJ, Nicholson WJ, Grantham JA, et al. Percutaneous axillary access for placement of microaxial ventricular support devices: The axillary access registry to monitor safety (ARMS). Circ Cardiovasc Interv. 2021;14:e009657.","journal-title":"Circ Cardiovasc Interv"},{"key":"2029_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jcin.2022.09.038","volume":"16","author":"L Azzalini","year":"2023","unstructured":"Azzalini L, Condos G, Kearney KE, Lombardi WL, McCabe JM. Mechanical circulatory support via percutaneous transcarotid access for high-risk percutaneous coronary intervention. JACC Cardiovasc Interv. 2023;16:106\u20138.","journal-title":"JACC Cardiovasc Interv"},{"key":"2029_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.15420\/usc.2021.15","volume":"15","author":"R Upadhyay","year":"2021","unstructured":"Upadhyay R, Alrayes H, Arno S, Kaushik M, Basir MB. Current landscape of temporary percutaneous mechanical circulatory support technology. US Cardiol Rev. 2021;15:15-e21.","journal-title":"US Cardiol Rev"},{"key":"2029_CR29","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1002\/ccd.22929","volume":"82","author":"JC Kovacic","year":"2013","unstructured":"Kovacic JC, Nguyen HT, Karajgikar R, Sharma SK, Kini AS. The impella recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention. Catheter Cardiovasc Interv. 2013;82:E28-37.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2029_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.amjcard.2023.09.023","volume":"208","author":"KD Gandhi","year":"2023","unstructured":"Gandhi KD, Moras EC, Niroula S, Lopez PD, Aggarwal D, Bhatia K, et al. Left ventricular unloading with impella versus IABP in patients with VA-ECMO: a systematic review and meta-analysis. Am J Cardiol. 2023;208:53\u20139.","journal-title":"Am J Cardiol"},{"key":"2029_CR31","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/j.jcin.2022.05.033","volume":"15","author":"M Chiang","year":"2022","unstructured":"Chiang M, Gonzalez PE, Basir MB, O\u2019Neill BP, Lee J, Frisoli T, et al. Modified Transcaval left atrial venoarterial extracorporeal membrane oxygenation without preplanning contrast CT: Step-by-step guide. JACC Cardiovasc Interv. 2022;15:e181\u20135.","journal-title":"JACC Cardiovasc Interv"},{"key":"2029_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5339\/qmj.2017.swacelso.39","volume":"2017","author":"SAM Al Hanshi","year":"2017","unstructured":"Al Hanshi SAM, Al OF. A case study of Harlequin syndrome in VA-ECMO. Qatar Med J. 2017;2017:39.","journal-title":"Qatar Med J"},{"key":"2029_CR33","doi-asserted-by":"crossref","unstructured":"Bai M, Lu A, Pan C, Hu S, Qu W, Zhao J, et al. Veno-arterial extracorporeal membrane oxygenation in elective high-risk percutaneous coronary interventions. Front Med (Lausanne). 2022;9.","DOI":"10.3389\/fmed.2022.913403"},{"key":"2029_CR34","first-page":"456","volume":"30","author":"A Shaukat","year":"2018","unstructured":"Shaukat A, Hryniewicz-Czeneszew K, Sun B, Mudy K, Wilson K, Tajti P, et al. Outcomes of extracorporeal membrane oxygenation support for complex high-risk elective percutaneous coronary interventions: a single-center experience and review of the literature. J Invasive Cardiol. 2018;30:456\u201360.","journal-title":"J Invasive Cardiol"},{"key":"2029_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12471-019-01350-8","volume":"28","author":"FS van den Brink","year":"2020","unstructured":"van den Brink FS, Meijers TA, Hofma SH, van Boven AJ, Nap A, Vonk A, et al. Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention. Neth Hear J. 2020;28:139\u201344.","journal-title":"Neth Hear J"},{"key":"2029_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.hrtlng.2015.03.005","volume":"44","author":"SD Tomasello","year":"2015","unstructured":"Tomasello SD, Boukhris M, Ganyukov V, Galassi AR, Shukevich D, Haes B, et al. Outcome of extracorporeal membrane oxygenation support for complex high-risk elective percutaneous coronary interventions: a single-center experience. Heart and Lung: Journal of Acute and Critical Care. 2015;44:309\u201313.","journal-title":"Heart and Lung: Journal of Acute and Critical Care"},{"key":"2029_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijcard.2019.10.020","volume":"297","author":"A Samol","year":"2019","unstructured":"Samol A, Schmidt S, Zeyse M, Wiemer M, Luani B. High-risk PCI under support of a pulsatile left ventricular assist device \u2013 First German experience with the iVAC2L system. Int J Cardiol. 2019;297:30\u20135.","journal-title":"Int J Cardiol"},{"key":"2029_CR38","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.4244\/EIJ-D-16-00371","volume":"12","author":"CAD Uil","year":"2017","unstructured":"Uil CAD, Daemen J, Lenzen MJ, Maugenest AM, Joziasse L, Van Geuns RJ, et al. Pulsatile iVAC 2L circulatory support in high-risk percutaneous coronary intervention. EuroIntervention. 2017;12:1689\u201396.","journal-title":"EuroIntervention"},{"key":"2029_CR39","doi-asserted-by":"crossref","unstructured":"De Maria GL, Garcia-Garcia HM, Scarsini R, Finn A, Sato Y, Virmani R, et al. Novel device-based therapies to improve outcome in ST-segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. Oxford University Press; 2021:687\u201397.","DOI":"10.1093\/ehjacc\/zuab012"},{"key":"2029_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1540-8183.2012.00768.x","volume":"25","author":"TP Van de Hoef","year":"2012","unstructured":"Van de Hoef TP, Nolte F, Delewi R, Henriques JPS, Spaan JAE, Tijssen JGP, et al. Intracoronary hemodynamic effects of pressure-controlled intermittent coronary sinus occlusion (PICSO): results from the First-In-Man Prepare PICSO Study. J Interv Cardiol. 2012;25:549\u201356.","journal-title":"J Interv Cardiol"},{"key":"2029_CR41","doi-asserted-by":"publisher","first-page":"e1437","DOI":"10.4244\/EIJ-D-16-00096","volume":"12","author":"L Azzalini","year":"2016","unstructured":"Azzalini L, Montorfano M, Latib A, Colombo A. High-risk left main percutaneous coronary intervention supported by pressure-controlled intermittent coronary sinus occlusion. EuroIntervention. 2016;12:e1437\u2013e1437.","journal-title":"EuroIntervention"},{"key":"2029_CR42","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0735-1097(96)00249-5","volume":"28","author":"MJ Williams","year":"1996","unstructured":"Williams MJ, Dow CJ, Newell JB, Palacios IF, Picard MH. Prevalence and timing of regional myocardial dysfunction after rotational coronary atherectomy. J Am Coll Cardiol. 1996;28:861\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"2029_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.15420\/icr.2021.11","volume":"17","author":"R Zein","year":"2022","unstructured":"Zein R, Patel C, Mercado-Alamo A, Schreiber T, Kaki A. A review of the impella devices. Interv Cardiol: Rev Res Resour. 2022;17:17\u2013e05.","journal-title":"Interv Cardiol: Rev Res Resour"},{"key":"2029_CR44","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ccd.27650","volume":"92","author":"L Smith","year":"2018","unstructured":"Smith L, Peters A, Mazimba S, Ragosta M, Taylor AM. Outcomes of patients with cardiogenic shock treated with TandemHeart\u00ae percutaneous ventricular assist device: Importance of support indication and definitive therapies as determinants of prognosis. Catheter Cardiovasc Interv. 2018;92:1173\u201381.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2029_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MAT.0000000000001344","volume":"67","author":"ASC Richardson","year":"2021","unstructured":"Richardson ASC, Tonna JE, Nanjayya V, Nixon P, Abrams DC, Raman L. Extracorporeal cardiopulmonary resuscitation in adults. Interim guideline consensus statement from the extracorporeal life support organization. ASAIO J. 2021;67:221\u20138.","journal-title":"ASAIO J"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02029-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-024-02029-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-024-02029-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T11:10:31Z","timestamp":1712229031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-024-02029-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2029"],"URL":"https:\/\/doi.org\/10.1007\/s11886-024-02029-2","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"assertion":[{"value":"13 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Villablanca received consulting fees from Abiomed, Livanova, Edwards, Teleflex, and Angiodynamic. Dr. Patel received consulting fees from Medtronic, Abiomed, Abbott Vascular, Edwards Lifesciences, Shockwave, and Heartflow; serves on the advisory board of Abiomed and Medtronic. Dr. Azzalini received consulting fees from Teleflex, Abiomed, GE Healthcare, Abbott Vascular, Reflow Medical, and Cardiovascular Systems, Inc.; serves on the advisory board of Abiomed and GE Healthcare; and owns equity in Reflow Medical. The other authors have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}